PhD, A. R. A., PhD, Y. A., PharmD, M. S. A., PharmD, O. A. A., PharmD, T. Z. A., PharmD, S. I. A. D., . . . PhD, O. A. A. Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia. SAGE Publishing.
Chicago Style (17th ed.) CitationPhD, Abdulaali R. Almutairi, et al. Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia. SAGE Publishing.
MLA (9th ed.) CitationPhD, Abdulaali R. Almutairi, et al. Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia. SAGE Publishing.
Warning: These citations may not always be 100% accurate.